ArticleJournal of immunology research2019

A Novel Anti-EGFR mAb Ame55 with Lower Toxicity and Better Efficacy than Cetuximab When Combined with Irinotecan.

Weiyi Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.